Gutierrez-Ramos Jose-Carlos
- SEC CIK
- 0001667657
No open-market purchases or sales filed in the past year.
Current role at each company
- DHR Danaher CorpSVP, Chief Science Officeras of Aug 6, 2026
- BCYC Bicycle Therapeutics PLCDirectoras of Jan 6, 2026
- EVLO Evelo Biosciences, Inc.Directoras of Jun 12, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gutierrez-Ramos Jose-Carlos as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DHR Danaher Corp
SVP, Chief Science Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2023 (view filing) | Aug 21 | 1 day | Gutierrez-Ramos Jose-CarlosSVP, Chief Science Officer | SSale | −590 | $250.54 | −$147.8K | −7.8%6.94K after | |
| May 2, 2023 (view filing) | May 1 | 1 day | Gutierrez-Ramos Jose-CarlosSVP, Chief Science Officer | SSale | −500 | $242.19 | −$121.1K | −6.2%7.53K after |